Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

March 31, 2006

Conditions
Diabetes Mellitus
Interventions
DRUG

FK614

Trial Locations (36)

17011

Physicians for Clinical Research, Camp Hill

17254

SFM Clinical Trials, Scotland

19124

Founders Research Corp., Philadelphia

19522

Fleetwood Medical Associates, Fleetwood

23249

McGuire Research Institute, Richmond

25701

University Physicians Internal Medicine, Huntington

27834

Physician's East, Greenville

30322

The Emory Clinic, Atlanta

33021

Center for Diabetes and Endocrine Care, Hollywood

33136

Physician's Office, Miami

University of Miami, Diabetes Center, Miami

33176

Baptist Diabetes Associates, Miami

33321

Clireco, Inc., Tamarac

34761

Central Florida Clinical Studies, Ocoee

36360

International Institute of Clinical Research, Inc., Ozark

37825

Heartland Medical PC, New Tazewell

44195

Cleveland Clinic, Cleveland

44260

Radiant Research, Mogadorf

55435

Radiant Research - Minneapolis, Edina

61614

Physician's Office, Peoria

75390

University of Texas Southwestern Medical Center, Dallas

77030

Baylor College of Medicine, Houston

77081

Mercury Research, Inc., Houston

78229

Diabetes / Glandular Disease Research Associates, San Antonio

Sam Clinical Research Center, San Antonio

83651

McConnehey Family Medicine, Nampa

85712

Arizona Research Associates, Tucson

90035

Research Foundation of America, Los Angeles

90630

OCCR @ East Gate Medical Center, Cypress

92083

Progressive Clinical Research, Vista

92835

Clinical Trials of St. Jude Heritage Md Grp, Fullerton

94598

Diablo Clinical Research, Inc., Walnut Creek

96813

East-West Medical Institute, Honolulu

97232

Physician's Office, Portland

99216

Physician's Office, Spokane

02453

Clinical Research, Inc., Waltham

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00036192 - Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea | Biotech Hunter | Biotech Hunter